Cairo – Mubasher: B Investments Holding recently allocated EGP 300 million to EZ International, according to a bourse statement.
The listed company carried out the transaction through its 60%-owned B Pharma, which is an investment vehicle designated to invest in EZ International.
It is worth noting that earlier this year, Egypt’s TSFE Healthcare & Pharma Subfund joined forces with B Investments and El-Ezaby Pharmacy to establish EZ International.
Meanwhile, the parent company’s consolidated net profits after tax amounted to EGP 463.83 million in the first quarter (Q1) of 2023, including minority interest.
